|
|
||||||||
The FASEB Journal, Vol 3, 2282-2284, Copyright © 1989 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
ME Hiltz and JM Lipton
Department of Physiology, University of Texas Southwestern Medical Center, Dallas 75235.
The endogenous neuropeptide alpha-melanocyte stimulating hormone (alpha- MSH 1-13), previously found to have marked antipyretic activity, inhibits histamine-induced increases in vasopermeability. The primary antipyretic amino acid message sequence is believed to be the COOH- terminal trieptide, lysine-proline-valine. In recent preliminary research this tripeptide inhibited increases in vasopermeability, raising the possibility that this portion of the alpha-MSH molecule has general antiinflammatory activity. To test this idea, the effects of graded doses of alpha-MSH [11-13] on ear swelling induced by picryl chloride in mice were compared with the effects of saline and a large dose of corticosteroid. Alpha-MSH [11-13] inhibited swelling in a dose- related fashion. This result, together with previous findings, suggests that endogenous circulating alpha-MSH and its COOH-terminal fragments may contribute to modulation of physiological responses in host defense. If this is true, it may be possible to develop new peptide drugs or mimetics based on the tripeptide that are useful in treating inflammation.
This article has been cited by other articles:
![]() |
T. Brzoska, T. A. Luger, C. Maaser, C. Abels, and M. Bohm {alpha}-Melanocyte-Stimulating Hormone and Related Tripeptides: Biochemistry, Antiinflammatory and Protective Effects in Vitro and in Vivo, and Future Perspectives for the Treatment of Immune-Mediated Inflammatory Diseases Endocr. Rev., August 1, 2008; 29(5): 581 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Maaser, K Kannengiesser, C Specht, A Lugering, T Brzoska, T A Luger, W Domschke, and T Kucharzik Crucial role of the melanocortin receptor MC1R in experimental colitis Gut, October 1, 2006; 55(10): 1415 - 1422. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Catania, S. Gatti, G. Colombo, and J. M. Lipton Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation Pharmacol. Rev., March 1, 2004; 56(1): 1 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Barcellini, G. Colombo, L. La Maestra, G. Clerici, L. Garofalo, A. T. Brini, J. M. Lipton, and A. Catania {alpha}-Melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes J. Leukoc. Biol., November 1, 2000; 68(5): 693 - 699. [Abstract] [Full Text] |
||||
![]() |
J. W. Haycock, S. J. Rowe, S. Cartledge, A. Wyatt, G. Ghanem, R. Morandini, I. G. Rennie, and S. MacNeil alpha -Melanocyte-stimulating Hormone Reduces Impact of Proinflammatory Cytokine and Peroxide-generated Oxidative Stress on Keratinocyte and Melanoma Cell Lines J. Biol. Chem., May 19, 2000; 275(21): 15629 - 15636. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |